CNBCBristol Myers to buy RayzeBio for about $4.1 billion by TheCompaniesDecember 26, 20230 Share0 Facebook Twitter Google+ Pinterest Amazon reddit LinkedIn Myspace Bristol Myers Squibb said on Tuesday it will acquire radiopharmaceutical firm RayzeBio for about $4.1 billion.
